Autumn Glory Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,367
Closed -$1.47M 218
2025
Q4
$1.47M Sell
1,367
-311
-19% -$297K 0.51% 54
2025
Q3
$1.28M Buy
1,678
+634
+61% +$472K 0.53% 53
2025
Q2
$814K Buy
1,044
+341
+49% +$265K 0.38% 71
2025
Q1
$2.58M Buy
703
+12
+2% +$9.98K 1.28% 19
2024
Q4
$533K Buy
+691
New +$572K 0.26% 94

Other funds holding LLY

Autumn Glory Partners's LLY Position: Q1 2026 in Review

Autumn Glory Partners sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 1,367 shares — an estimated $1.47M sold.

Autumn Glory Partners first reported a position in LLY in Q4 2024 and held it in 5 quarters. The position peaked at $2.58M in Q1 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Autumn Glory Partners reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Autumn Glory Partners sold 1,367 Eli Lilly shares in Q1 2026, an estimated $1.47M.
  • Autumn Glory Partners first reported a position in Eli Lilly in Q4 2024 and held it in 5 quarters.
  • Autumn Glory Partners's Eli Lilly position peaked at $2.58M in Q1 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Autumn Glory Partners's 13F filing for Q1 2026, filed 4 May 2026.